GELS logo

Gelteq Limited Stock Price

NasdaqCM:GELS Community·US$9.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

GELS Share Price Performance

US$0.87
-1.59 (-64.63%)
US$0.87
-1.59 (-64.63%)
Price US$0.87

GELS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with mediocre balance sheet.

5 Risks
0 Rewards

Gelteq Limited Key Details

AU$413.1k

Revenue

AU$115.4k

Cost of Revenue

AU$297.7k

Gross Profit

AU$6.9m

Other Expenses

-AU$6.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.62
72.07%
-1,608.55%
26.7%
View Full Analysis

About GELS

Founded
2017
Employees
8
CEO
Nathan Givoni
WebsiteView website
www.gelteq.com

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Recent GELS News & Updates

We Think Gelteq (NASDAQ:GELS) Has A Fair Chunk Of Debt

Nov 24
We Think Gelteq (NASDAQ:GELS) Has A Fair Chunk Of Debt

Recent updates

No updates